AP9200428A0 - Compounds for treating leukotriene-related diseases - Google Patents

Compounds for treating leukotriene-related diseases

Info

Publication number
AP9200428A0
AP9200428A0 AP92/00428A AP9200428A AP9200428A0 AP 9200428 A0 AP9200428 A0 AP 9200428A0 AP 92/00428 A AP92/00428 A AP 92/00428A AP 9200428 A AP9200428 A AP 9200428A AP 9200428 A0 AP9200428 A0 AP 9200428A0
Authority
AP
ARIPO
Prior art keywords
compounds
related diseases
treating leukotriene
leukotriene
treating
Prior art date
Application number
AP92/00428A
Other versions
AP333A (en
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of AP9200428A0 publication Critical patent/AP9200428A0/en
Application granted granted Critical
Publication of AP333A publication Critical patent/AP333A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/65One oxygen atom attached in position 3 or 5
APAP/P/1992/000428A 1991-09-19 1992-09-17 Phenyl-substituted pyridyl aliphatic compounds for treating leukotriene-related diseases. AP333A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US76271091A 1991-09-19 1991-09-19
US79093191A 1991-11-12 1991-11-12
US80959391A 1991-12-18 1991-12-18
US93286992A 1992-08-20 1992-08-20
CN93103596A CN1092409A (en) 1991-09-19 1993-03-19 The compound that is used for the treatment of leukotriene-related disease

Publications (2)

Publication Number Publication Date
AP9200428A0 true AP9200428A0 (en) 1992-10-31
AP333A AP333A (en) 1994-04-25

Family

ID=36809157

Family Applications (1)

Application Number Title Priority Date Filing Date
APAP/P/1992/000428A AP333A (en) 1991-09-19 1992-09-17 Phenyl-substituted pyridyl aliphatic compounds for treating leukotriene-related diseases.

Country Status (12)

Country Link
EP (1) EP0604529A1 (en)
JP (1) JPH06510786A (en)
CN (1) CN1092409A (en)
AP (1) AP333A (en)
AU (1) AU2573592A (en)
CA (1) CA2119467A1 (en)
IL (1) IL103205A0 (en)
MA (1) MA22649A1 (en)
MX (1) MX9205358A (en)
NZ (1) NZ244371A (en)
PT (1) PT100881A (en)
WO (1) WO1993006085A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994000433A1 (en) * 1992-06-30 1994-01-06 Smithkline Beecham Corporation Process for making phenylthiomethylpyridinylalkenoates
GB9313145D0 (en) * 1993-06-25 1993-08-11 Smithkline Beecham Plc Process
IL115420A0 (en) 1994-09-26 1995-12-31 Zeneca Ltd Aminoheterocyclic derivatives
DE69609820T2 (en) * 1995-03-02 2001-03-08 Smithkline Beecham Corp Use of substituted pyridine compounds for the treatment of atopic dermatitis and contact dermatitis
GB9508137D0 (en) * 1995-04-21 1995-06-07 Smithkline Beecham Plc Formulation
WO1997028128A1 (en) 1996-02-02 1997-08-07 Zeneca Limited Heterocyclic compounds useful as pharmaceutical agents
GB9602166D0 (en) 1996-02-02 1996-04-03 Zeneca Ltd Aminoheterocyclic derivatives
US5929096A (en) * 1996-02-29 1999-07-27 Smithkline Beecham Corporation Method for treating atopic dermatitis and contact dermatitis
ATE230399T1 (en) * 1996-08-14 2003-01-15 Astrazeneca Ab SUBSTITUTED PYRIMIDINE DERIVATIVES AND THEIR PHARMACEUTICAL USE
AU4557397A (en) 1996-09-26 1998-04-17 Novartis Ag Aryl-substituted acrylamides with leukotriene b4 (ltb-4) receptor antagonist activity
UA56197C2 (en) 1996-11-08 2003-05-15 Зенека Лімітед Heterocyclic derivatives
AU5999698A (en) 1997-02-13 1998-09-08 Zeneca Limited Heterocyclic compounds useful as oxido-squalene cyclase inhibitors
WO1998035959A1 (en) 1997-02-13 1998-08-20 Zeneca Limited Heterocyclic compounds useful as oxido-squalene cyclase inhibitors
GB9715895D0 (en) 1997-07-29 1997-10-01 Zeneca Ltd Heterocyclic compounds
GB9902989D0 (en) 1999-02-11 1999-03-31 Zeneca Ltd Heterocyclic derivatives

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4056619A (en) * 1975-09-08 1977-11-01 Warner-Lambert Company 1-Substituted-2-(2-pyridinyl)ethanone N-oxides
US5004743A (en) * 1987-11-25 1991-04-02 Merck Frosst Canada, Inc. Pyridyl styrene dialkanoic acids as anti-leukotriene agents
AU655428B2 (en) * 1990-06-07 1994-12-22 Smithkline Beecham Corporation Benzoic acid derivatives

Also Published As

Publication number Publication date
CA2119467A1 (en) 1993-04-01
PT100881A (en) 1993-10-29
JPH06510786A (en) 1994-12-01
CN1092409A (en) 1994-09-21
MX9205358A (en) 1993-07-01
EP0604529A1 (en) 1994-07-06
NZ244371A (en) 1995-11-27
AP333A (en) 1994-04-25
MA22649A1 (en) 1993-04-01
AU2573592A (en) 1993-04-27
WO1993006085A1 (en) 1993-04-01
IL103205A0 (en) 1993-02-21

Similar Documents

Publication Publication Date Title
EP0714302A4 (en) Therapeutic compounds
GB9127150D0 (en) Novel treatment
GB9215633D0 (en) Novel treatment
AP9200453A0 (en) Medicaments for treating inflammatory conditions or for analgiesia
IL103205A0 (en) Compounds for treating leukotriene-related diseases
GB9310199D0 (en) Therapeutic compounds
GB9211148D0 (en) Novel treatment
ZA914322B (en) Pyridyl-benzoic acid derivatives for treating leukotrienerelated diseases
AP9400637A0 (en) Therapeutic c compounds
GB9117819D0 (en) Therapeutic compounds
ZA942911B (en) Therapeutic compounds
AP9300527A0 (en) Novel treatment
GB9203637D0 (en) Novel treatment
ZA927160B (en) Compounds for treating leukotriene-related diseases.
GB9214239D0 (en) Compounds useful for treating tumours
GB9124541D0 (en) Therapeutic compounds
GB9102376D0 (en) Therapeutic compounds
GB9102341D0 (en) Therapeutic compounds
GB9102340D0 (en) Therapeutic compounds
GB9000691D0 (en) Therapeutic compounds
GB9020266D0 (en) Therapeutic compounds
GB9226526D0 (en) Therapeutic compounds
GB9222934D0 (en) Therapeutic compounds
GB9114335D0 (en) Compounds useful for treating tumours
GB9127354D0 (en) Agents for therapy